Droxidopa
Active substance: droxidopa
CAPSULE · DROXIDOPA 200 mg/1
United StatesActive
Marketing holder: CivicaScript LLC
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- DROXIDOPA · 200 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-36a8-79f1-93ae-433ac39a4da7,01a1208c-44ac-7a80-a002-7a6c26690143,01a1208c-6f3b-78ec-bd43-f49fb044fba0,01a1208c-8113-77f6-8f9a-57431ebb3f85,01a1208c-af2f-770f-9517-c117ab71c658;count=45 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 82249-552
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 82249-552 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 82249-552 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 82249-552 · Verified 2026-10-09 · open in source